HX-015

N/A

Report date: 2021/12/24 15:25:42

Base Information

Drug NameHX-015
Drug Alias NameHX-015
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Cluster of differentiation 47Anti-Vascular endothelial growth factor
TargetsCluster of differentiation 47Vascular endothelial growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHanx Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanx Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A